These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10890740)

  • 1. Potential of allospecific gene-engineered T cells in transplantation gene therapy: specific T cell activation determines transgene expression in vitro and in vivo.
    Hammer MH; Flügel A; Seifert M; Lehmann M; Brandt C; Volk HD; Ritter T
    Hum Gene Ther; 2000 Jun; 11(9):1303-11. PubMed ID: 10890740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral vectors for high-level transgene expression in T lymphocytes.
    Engels B; Cam H; Schüler T; Indraccolo S; Gladow M; Baum C; Blankenstein T; Uckert W
    Hum Gene Ther; 2003 Aug; 14(12):1155-68. PubMed ID: 12908967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-dependent transgene expression in kidney transplantation: a novel approach using gene-engineered T lymphocytes.
    Hammer MH; Schröder G; Risch K; Flügel A; Volk HD; Lehmann M; Ritter T
    J Am Soc Nephrol; 2002 Feb; 13(2):511-518. PubMed ID: 11805182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracking the immunoregulatory mechanisms active during allograft tolerance.
    Sánchez-Fueyo A; Weber M; Domenig C; Strom TB; Zheng XX
    J Immunol; 2002 Mar; 168(5):2274-81. PubMed ID: 11859115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costimulation of transduced T lymphocytes via T cell receptor-CD3 complex and CD28 leads to increased transcription of integrated retrovirus.
    Pollok KE; van der Loo JC; Cooper RJ; Kennedy L; Williams DA
    Hum Gene Ther; 1999 Sep; 10(13):2221-36. PubMed ID: 10498253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors.
    Chinnasamy N; Chinnasamy D; Toso JF; Lapointe R; Candotti F; Morgan RA; Hwu P
    Hum Gene Ther; 2000 Sep; 11(13):1901-9. PubMed ID: 10986562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of CTLA4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro.
    Takayama T; Morelli AE; Robbins PD; Tahara H; Thomson AW
    Gene Ther; 2000 Aug; 7(15):1265-73. PubMed ID: 10918497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human alloantigen-specific anergic cells induced by a combination of CTLA4-Ig and CsA maintain anti-leukemia and anti-viral cytotoxic responses.
    Comoli P; Locatelli F; Moretta A; Montagna D; Calcaterra V; Cometa A; Basso S; Zecca M; Maccario R
    Bone Marrow Transplant; 2001 Jun; 27(12):1263-73. PubMed ID: 11548844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-efficiency gene transfer into rhesus macaque primary T lymphocytes by combining 32 degrees C centrifugation and CH-296-coated plates: effect of gene transfer protocol on T cell homing receptor expression.
    Zhou P; Lee J; Moore P; Brasky KM
    Hum Gene Ther; 2001 Oct; 12(15):1843-55. PubMed ID: 11589827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local high-capacity adenovirus-mediated mCTLA4Ig and mCD40Ig expression prolongs recombinant gene expression in skeletal muscle.
    Jiang ZL; Reay D; Kreppel F; Gambotto A; Feingold E; Kochanek S; McCarthy SA; Clemens PR
    Mol Ther; 2001 Jun; 3(6):892-900. PubMed ID: 11407903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival.
    Comer RM; King WJ; Ardjomand N; Theoharis S; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1095-103. PubMed ID: 11923251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: targeted ligation of CTLA-4 in vivo by membrane-bound anti-CTLA-4 antibody prevents rejection of allogeneic cells.
    Hwang KW; Sweatt WB; Brown IE; Blank C; Gajewski TF; Bluestone JA; Alegre ML
    J Immunol; 2002 Jul; 169(2):633-7. PubMed ID: 12097362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.
    Jooss K; Turka LA; Wilson JM
    Gene Ther; 1998 Mar; 5(3):309-19. PubMed ID: 9614550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat.
    Bartlett AS; McCall JL; Ameratunga R; Howden B; Yeong ML; Benjamin CD; Hess D; Peach R; Munn SR
    Liver Transpl; 2002 May; 8(5):458-68. PubMed ID: 12004346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer.
    Zhao-Emonet JC; Marodon G; Pioche-Durieu C; Cosset FL; Klatzmann D
    J Gene Med; 2000; 2(6):416-25. PubMed ID: 11199262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease.
    Costa GL; Benson JM; Seroogy CM; Achacoso P; Fathman CG; Nolan GP
    J Immunol; 2000 Apr; 164(7):3581-90. PubMed ID: 10725713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of alloantigen-specific T cell tolerance through the treatment of human T lymphocytes with wortmannin.
    Taub DD; Murphy WJ; Asai O; Fenton RG; Peltz G; Key ML; Turcovski-Corrales S; Longo DL
    J Immunol; 1997 Mar; 158(6):2745-55. PubMed ID: 9058809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral vector persistence in vivo with a soluble form of CTLA4.
    Paillard F
    Hum Gene Ther; 1998 Aug; 9(12):1699-700. PubMed ID: 9721079
    [No Abstract]   [Full Text] [Related]  

  • 19. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
    J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.